logo
Select company
Select metric
-847.68%EBITDA Margin
VS
Market
6
Sector
20
Industry
5
History
68
$ 13.89Close
$ 8.25 - $ 29.25 52-Week Range
Ticker Information

Ticker

POAI

Company Name

PREDICTIVE ONCOLOGY INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

PREDICTIVE ONCOLOGY INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

POAI - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -9.07M-847.68%$ 1.07M
3/31/2025$ -10.19M-756.83%$ 1.35M
12/31/2024$ -11.97M-737.07%$ 1.62M
9/30/2024$ -13.69M-992.67%$ 1.38M
6/30/2024$ -13.39M-765.87%$ 1.75M
3/31/2024$ -14.12M-720.31%$ 1.96M
12/31/2023$ -13.24M-744.04%$ 1.78M
9/30/2023$ -17.51M-968.25%$ 1.81M
6/30/2023$ -18.24M-1177.25%$ 1.55M
3/31/2023$ -24.56M-1716.64%$ 1.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PREDICTIVE ONCOLOGY INC's latest trailing twelve months (TTM) EBITDA % stands at -2069.8%.
  • Over the past 5 years, PREDICTIVE ONCOLOGY INC's average EBITDA % has been -1319.66%.
  • The median EBITDA % for PREDICTIVE ONCOLOGY INC during this period was -1302.3%
  • PREDICTIVE ONCOLOGY INC reached its highest EBITDA % over the past 5 years at -720.31%.
  • The lowest EBITDA % recorded by PREDICTIVE ONCOLOGY INC in the same timeframe -2069.8%

PREDICTIVE ONCOLOGY INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
PAVM : PAVMED INC 7183.63%CODX : CO-DIAGNOSTICS INC -3454.54%APRE : APREA THERAPEUTICS INC -1763.89%LUCY : INNOVATIVE EYEWEAR INC -383.4%LYRA : LYRA THERAPEUTICS INC -4983.38%STSS : SHARPS TECHNOLOGY INC 942.03%VYNE : VYNE THERAPEUTICS INC -8093.49%SXTP : 60 DEGREES PHARMACEUTICALS INC -910.27%BRTX : BIORESTORATIVE THERAPIES INC -1725.43%SPRB : SPRUCE BIOSCIENCES INC -3526.87%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for PREDICTIVE ONCOLOGY INC is calculated as follows: EBITDA [ $ -27.03M ] / Revenues [ $ 1.31M ]
(=) EBITDA % [ -2069.8% ]

POAI - EBITDA Margin, Last 5 years

-2069.8%

Minimum

Sep 30, 2020

-720.31%

Maximum

Mar 31, 2024

-1319.66%

Average

-1302.3%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%